{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T02:33:03Z","timestamp":1776479583799,"version":"3.51.2"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T00:00:00Z","timestamp":1471564800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s00125-016-4075-4","type":"journal-article","created":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T02:40:20Z","timestamp":1471574420000},"page":"2467-2476","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Soluble CD163, adiponectin, C-reactive protein and progression of dysglycaemia in individuals at high risk of type 2 diabetes mellitus: the ADDITION-PRO cohort"],"prefix":"10.1007","volume":"59","author":[{"given":"Pia","family":"Deichgr\u00e6ber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel R.","family":"Witte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger J.","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette V.","family":"Skriver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f8rn","family":"Richelsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marit E.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanna B.","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annelli","family":"Sandb\u00e6k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,19]]},"reference":[{"key":"4075_CR1","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s001250051058","volume":"41","author":"JC Pickup","year":"1998","unstructured":"Pickup JC, Crook MA (1998) Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41:1241\u20131248","journal-title":"Diabetologia"},{"key":"4075_CR2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.diabres.2014.04.006","volume":"105","author":"N Esser","year":"2014","unstructured":"Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N (2014) Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract 105:141\u2013150","journal-title":"Diabetes Res Clin Pract"},{"key":"4075_CR3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.immuni.2014.05.010","volume":"41","author":"JC McNelis","year":"2014","unstructured":"McNelis JC, Olefsky JM (2014) Macrophages, immunity, and metabolic disease. Immunity 41:36\u201348","journal-title":"Immunity"},{"key":"4075_CR4","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1182\/blood.V99.1.378","volume":"99","author":"HJ Moller","year":"2002","unstructured":"Moller HJ, Peterslund NA, Graversen JH, Moestrup SK (2002) Identification of the hemoglobin scavenger receptor\/CD163 as a natural soluble protein in plasma. Blood 99:378\u2013380","journal-title":"Blood"},{"key":"4075_CR5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1189\/jlb.1205756","volume":"80","author":"LK Weaver","year":"2006","unstructured":"Weaver LK, Hintz-Goldstein KA, Pioli PA et al (2006) Pivotal advance: activation of cell surface Toll-like receptors causes shedding of the hemoglobin scavenger receptor CD163. J Leukoc Biol 80:26\u201335","journal-title":"J Leukoc Biol"},{"key":"4075_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00365513.2011.626868","volume":"72","author":"HJ Moller","year":"2012","unstructured":"Moller HJ (2012) Soluble CD163. Scand J Clin Lab Invest 72:1\u201313","journal-title":"Scand J Clin Lab Invest"},{"key":"4075_CR7","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1007\/s00125-012-2533-1","volume":"55","author":"T Parkner","year":"2012","unstructured":"Parkner T, Sorensen LP, Nielsen AR et al (2012) Soluble CD163: a biomarker linking macrophages and insulin resistance. Diabetologia 55:1856\u20131862","journal-title":"Diabetologia"},{"key":"4075_CR8","doi-asserted-by":"crossref","first-page":"e101250","DOI":"10.1371\/journal.pone.0101250","volume":"9","author":"G Rojo-Martinez","year":"2014","unstructured":"Rojo-Martinez G, Maymo-Masip E, Rodriguez MM et al (2014) Serum sCD163 levels are associated with type 2 diabetes mellitus and are influenced by coffee and wine consumption: results of the Di@bet.es study. PLoS One 9:e101250","journal-title":"PLoS One"},{"key":"4075_CR9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2265.2011.04284.x","volume":"77","author":"MV Zanni","year":"2011","unstructured":"Zanni MV, Burdo TH, Makimura H, Williams KC, Grinspoon SK (2011) Relationship between monocyte\/macrophage activation marker soluble CD163 and insulin resistance in obese and normal-weight subjects. Clin Endocrinol (Oxf) 77:385\u2013390","journal-title":"Clin Endocrinol (Oxf)"},{"key":"4075_CR10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1373\/clinchem.2010.154724","volume":"57","author":"HJ Moller","year":"2011","unstructured":"Moller HJ, Frikke-Schmidt R, Moestrup SK, Nordestgaard BG, Tybjaerg-Hansen A (2011) Serum soluble CD163 predicts risk of type 2 diabetes in the general population. Clin Chem 57:291\u2013297","journal-title":"Clin Chem"},{"key":"4075_CR11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jmcb\/mjw011","volume":"8","author":"ZV Wang","year":"2016","unstructured":"Wang ZV, Scherer PE (2016) Adiponectin, the past two decades. J Mol Cell Biol 8:93\u2013100","journal-title":"J Mol Cell Biol"},{"key":"4075_CR12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/jmcb\/mjw014","volume":"8","author":"H Ruan","year":"2016","unstructured":"Ruan H, Dong LQ (2016) Adiponectin signaling and function in insulin target tissues. J Mol Cell Biol 8:101\u2013109","journal-title":"J Mol Cell Biol"},{"key":"4075_CR13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4239\/wjd.v6.i1.151","volume":"6","author":"K Ghoshal","year":"2015","unstructured":"Ghoshal K, Bhattacharyya M (2015) Adiponectin: probe of the molecular paradigm associating diabetes and obesity. World J Diabetes 6:151\u2013166","journal-title":"World J Diabetes"},{"key":"4075_CR14","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00125-008-1013-0","volume":"51","author":"A Sandbaek","year":"2008","unstructured":"Sandbaek A, Griffin SJ, Rutten G et al (2008) Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study. Diabetologia 51:1127\u20131134","journal-title":"Diabetologia"},{"key":"4075_CR15","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1186\/1471-2458-12-1078","volume":"12","author":"NB Johansen","year":"2012","unstructured":"Johansen NB, Hansen AL, Jensen TM et al (2012) Protocol for ADDITION-PRO: a longitudinal cohort study of the cardiovascular experience of individuals at high risk for diabetes recruited from Danish primary care. BMC Public Health 12:1078","journal-title":"BMC Public Health"},{"key":"4075_CR16","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1373\/clinchem.2005.051979","volume":"51","author":"P D\u2019Orazio","year":"2005","unstructured":"D\u2019Orazio P, Burnett RW, Fogh-Andersen N et al (2005) Approved IFCC recommendation on reporting results for blood glucose (abbreviated). Clin Chem 51:1573\u20131576","journal-title":"Clin Chem"},{"key":"4075_CR17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"4075_CR18","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","volume":"27","author":"TM Wallace","year":"2004","unstructured":"Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487\u20131495","journal-title":"Diabetes Care"},{"key":"4075_CR19","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(09)60619-X","volume":"373","author":"AG Tabak","year":"2009","unstructured":"Tabak AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimaki M, Witte DR (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373:2215\u20132221","journal-title":"Lancet"},{"key":"4075_CR20","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/oby.20376","volume":"21","author":"K Fjeldborg","year":"2013","unstructured":"Fjeldborg K, Christiansen T, Bennetzen M, J Moller H, Pedersen SB, Richelsen B (2013) The macrophage-specific serum marker, soluble CD163, is increased in obesity and reduced after dietary-induced weight loss. Obesity (Silver Spring) 21:2437\u20132443","journal-title":"Obesity (Silver Spring)"},{"key":"4075_CR21","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1055\/s-2006-925204","volume":"38","author":"C Thamer","year":"2006","unstructured":"Thamer C, Haap M, Heller E et al (2006) Beta cell function, insulin resistance and plasma adiponectin concentrations are predictors for the change of postprandial glucose in non-diabetic subjects at risk for type 2 diabetes. Horm Metab Res 38:178\u2013182","journal-title":"Horm Metab Res"},{"key":"4075_CR22","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-2265.2008.03344.x","volume":"70","author":"NR Bennett","year":"2009","unstructured":"Bennett NR, Boyne MS, Cooper RS et al (2009) Impact of adiponectin and ghrelin on incident glucose intolerance and on weight change. Clin Endocrinol (Oxf) 70:408\u2013414","journal-title":"Clin Endocrinol (Oxf)"},{"key":"4075_CR23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1210\/jc.2003-031163","volume":"89","author":"Y Yamamoto","year":"2004","unstructured":"Yamamoto Y, Hirose H, Saito I, Nishikai K, Saruta T (2004) Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: two-year follow-up study in Japanese population. J Clin Endocrinol Metab 89:87\u201390","journal-title":"J Clin Endocrinol Metab"},{"key":"4075_CR24","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1007\/s00125-015-3679-4","volume":"58","author":"B Kluppelholz","year":"2015","unstructured":"Kluppelholz B, Thorand B, Koenig W et al (2015) Association of subclinical inflammation with deterioration of glycaemia before the diagnosis of type 2 diabetes: the KORA S4\/F4 study. Diabetologia 58:2269\u20132277","journal-title":"Diabetologia"},{"key":"4075_CR25","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1055\/s-0029-1216359","volume":"41","author":"AG Tabak","year":"2009","unstructured":"Tabak AG, Brunner EJ, Miller MA et al (2009) Low serum adiponectin predicts 10-year risk of type 2 diabetes and HbA1c independently of obesity, lipids, and inflammation: Whitehall II study. Horm Metab Res 41:626\u2013629","journal-title":"Horm Metab Res"},{"key":"4075_CR26","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1007\/s00125-009-1486-5","volume":"52","author":"K Park","year":"2009","unstructured":"Park K, Steffes M, Lee DH, Himes JH, Jacobs DR Jr (2009) Association of inflammation with worsening HOMA-insulin resistance. Diabetologia 52:2337\u20132344","journal-title":"Diabetologia"},{"key":"4075_CR27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/EJE-10-0277","volume":"163","author":"AG Tabak","year":"2010","unstructured":"Tabak AG, Kivimaki M, Brunner EJ et al (2010) Changes in C-reactive protein levels before type 2 diabetes and cardiovascular death: the Whitehall II study. Eur J Endocrinol 163:89\u201395","journal-title":"Eur J Endocrinol"},{"key":"4075_CR28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1258\/acb.2007.006212","volume":"45","author":"B Carstensen","year":"2008","unstructured":"Carstensen B, Lindstrom J, Sundvall J, Borch-Johnsen K, Tuomilehto J, DPS Study Group (2008) Measurement of blood glucose: comparison between different types of specimens. Ann Clin Biochem 45:140\u2013148","journal-title":"Ann Clin Biochem"},{"key":"4075_CR29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0009-8981(01)00426-0","volume":"307","author":"K Kuwa","year":"2001","unstructured":"Kuwa K, Nakayama T, Hoshino T, Tominaga M (2001) Relationships of glucose concentrations in capillary whole blood, venous whole blood and venous plasma. Clin Chim Acta 307:187\u2013192","journal-title":"Clin Chim Acta"},{"key":"4075_CR30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cccn.2003.10.033","volume":"341","author":"M Kruijshoop","year":"2004","unstructured":"Kruijshoop M, Feskens EJ, Blaak EE, de Bruin TW (2004) Validation of capillary glucose measurements to detect glucose intolerance or type 2 diabetes mellitus in the general population. Clin Chim Acta 341:33\u201340","journal-title":"Clin Chim Acta"},{"key":"4075_CR31","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1373\/clinchem.2006.077784","volume":"53","author":"SE Manley","year":"2007","unstructured":"Manley SE, Stratton IM, Clark PM, Luzio SD (2007) Comparison of 11 human insulin assays: implications for clinical investigation and research. Clin Chem 53:922\u2013932","journal-title":"Clin Chem"},{"key":"4075_CR32","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.2337\/db12-0935","volume":"62","author":"H Gao","year":"2013","unstructured":"Gao H, Fall T, van Dam RM et al (2013) Evidence of a causal relationship between adiponectin levels and insulin sensitivity: a Mendelian randomization study. Diabetes 62:1338\u20131344","journal-title":"Diabetes"},{"key":"4075_CR33","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.2337\/db13-0128","volume":"62","author":"H Yaghootkar","year":"2013","unstructured":"Yaghootkar H, Lamina C, Scott RA et al (2013) Mendelian randomization studies do not support a causal role for reduced circulating adiponectin levels in insulin resistance and type 2 diabetes. Diabetes 62:3589\u20133598","journal-title":"Diabetes"},{"key":"4075_CR34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050155","volume":"5","author":"EJ Brunner","year":"2008","unstructured":"Brunner EJ, Kivimaki M, Witte DR et al (2008) Inflammation, insulin resistance, and diabetes\u2014Mendelian randomization using CRP haplotypes points upstream. PLoS Med 5, e155","journal-title":"PLoS Med"}],"updated-by":[{"DOI":"10.1007\/s00125-017-4498-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T00:00:00Z","timestamp":1512345600000}}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-016-4075-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-016-4075-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-016-4075-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T06:59:29Z","timestamp":1499756369000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-016-4075-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,19]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["4075"],"URL":"https:\/\/doi.org\/10.1007\/s00125-016-4075-4","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00125-017-4498-6","asserted-by":"object"}]},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,19]]}}}